Trademark: 90738229
Word
RALYANT
Status
Pending
Status Code
733
Status Date
Monday, February 26, 2024
Serial Number
90738229
Mark Type
4000
Filing Date
Thursday, May 27, 2021
Published for Opposition
Tuesday, January 4, 2022

Trademark Owner History

Classifications
5 Human pharmaceutical preparations for the prevention and treatment of viral diseases, auto-immune and inflammatory diseases, cardiovascular and pulmonary diseases, central nervous system diseases, peripheral neurological system diseases, pain, dermatologic diseases, gastro-intestinal diseases, infectious-related diseases, metabolic diseases, oncologic diseases, ophthalmic diseases, respiratory diseases, digital ulcers, and cerebrovascular diseases; vaccines; anxiolytics; anti-allergics; anti-infectives

Trademark Events
Feb 27, 2024
Notice Of Approval Of Extension Request E-Mailed
Feb 26, 2024
Sou Extension 4 Granted
Feb 26, 2024
Sou Extension 4 Filed
Feb 26, 2024
Sou Teas Extension Received
Aug 24, 2023
Notice Of Approval Of Extension Request E-Mailed
Aug 22, 2023
Sou Extension 3 Granted
Aug 22, 2023
Sou Extension 3 Filed
Aug 22, 2023
Sou Teas Extension Received
Feb 25, 2023
Notice Of Approval Of Extension Request E-Mailed
Feb 23, 2023
Sou Extension 2 Granted
Feb 23, 2023
Sou Extension 2 Filed
Feb 23, 2023
Sou Teas Extension Received
Aug 16, 2022
Notice Of Approval Of Extension Request E-Mailed
Aug 12, 2022
Sou Extension 1 Granted
Aug 12, 2022
Sou Extension 1 Filed
Aug 12, 2022
Sou Teas Extension Received
Mar 1, 2022
Noa E-Mailed - Sou Required From Applicant
Jan 4, 2022
Official Gazette Publication Confirmation E-Mailed
Jan 4, 2022
Published For Opposition
Dec 15, 2021
Notification Of Notice Of Publication E-Mailed
Nov 29, 2021
Approved For Pub - Principal Register
Nov 23, 2021
Assigned To Examiner
Aug 21, 2021
New Application Office Supplied Data Entered
May 31, 2021
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24